Market Overview
The global Insulin Like Growth Factor 1 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Insulin Like Growth Factor 1 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Insulin Like Growth Factor 1 Receptor market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Insulin Like Growth Factor 1 Receptor market has been segmented into BI-893923, CT-707, 1R-E1, ATL-1101, Others, etc.
Breakdown by Application, Insulin Like Growth Factor 1 Receptor has been segmented into Hospital, Clinic, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insulin Like Growth Factor 1 Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Insulin Like Growth Factor 1 Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insulin Like Growth Factor 1 Receptor market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Insulin Like Growth Factor 1 Receptor Market Share Analysis
Insulin Like Growth Factor 1 Receptor competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Insulin Like Growth Factor 1 Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insulin Like Growth Factor 1 Receptor sales, revenue and market share for each player covered in this report.
The major players covered in Insulin Like Growth Factor 1 Receptor are: Astellas Pharma Inc., Genmab A/S, Boehringer Ingelheim GmbH, AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Axelar AB, Insmed Incorporated, Eli Lilly and Company, Bristol-Myers Squibb Company, Immunomedics, Inc., ProteoThera, Inc., Merck & Co., Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Novartis AG, etc. Among other players domestic and global, Insulin Like Growth Factor 1 Receptor market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Insulin Like Growth Factor 1 Receptor market are listed below:
Astellas Pharma Inc.
Genmab A/S
Boehringer Ingelheim GmbH
AstraZeneca Plc
F. Hoffmann-La Roche Ltd.
Axelar AB
Insmed Incorporated
Eli Lilly and Company
Bristol-Myers Squibb Company
Immunomedics, Inc.
ProteoThera, Inc.
Merck & Co., Inc.
PharmAbcine, Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
BI-893923
CT-707
1R-E1
ATL-1101
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Insulin Like Growth Factor 1 Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Like Growth Factor 1 Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BI-893923
1.2.3 CT-707
1.2.4 1R-E1
1.2.5 ATL-1101
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Like Growth Factor 1 Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
1.4.1 Global Insulin Like Growth Factor 1 Receptor Revenue and Forecast (2015-2025)
1.4.2 Global Insulin Like Growth Factor 1 Receptor Sales and Forecast (2015-2025)
1.5 Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma Inc. SWOT Analysis
2.1.4 Astellas Pharma Inc. Product and Services
2.1.5 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genmab A/S
2.2.1 Genmab A/S Details
2.2.2 Genmab A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genmab A/S SWOT Analysis
2.2.4 Genmab A/S Product and Services
2.2.5 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim GmbH SWOT Analysis
2.3.4 Boehringer Ingelheim GmbH Product and Services
2.3.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca Plc
2.4.1 AstraZeneca Plc Details
2.4.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca Plc SWOT Analysis
2.4.4 AstraZeneca Plc Product and Services
2.4.5 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.5.4 F. Hoffmann-La Roche Ltd. Product and Services
2.5.5 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Axelar AB
2.6.1 Axelar AB Details
2.6.2 Axelar AB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Axelar AB SWOT Analysis
2.6.4 Axelar AB Product and Services
2.6.5 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Insmed Incorporated
2.7.1 Insmed Incorporated Details
2.7.2 Insmed Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Insmed Incorporated SWOT Analysis
2.7.4 Insmed Incorporated Product and Services
2.7.5 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly and Company SWOT Analysis
2.8.4 Eli Lilly and Company Product and Services
2.8.5 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb Company
2.9.1 Bristol-Myers Squibb Company Details
2.9.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb Company SWOT Analysis
2.9.4 Bristol-Myers Squibb Company Product and Services
2.9.5 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Immunomedics, Inc.
2.10.1 Immunomedics, Inc. Details
2.10.2 Immunomedics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Immunomedics, Inc. SWOT Analysis
2.10.4 Immunomedics, Inc. Product and Services
2.10.5 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ProteoThera, Inc.
2.11.1 ProteoThera, Inc. Details
2.11.2 ProteoThera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ProteoThera, Inc. SWOT Analysis
2.11.4 ProteoThera, Inc. Product and Services
2.11.5 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Merck & Co., Inc.
2.12.1 Merck & Co., Inc. Details
2.12.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Merck & Co., Inc. SWOT Analysis
2.12.4 Merck & Co., Inc. Product and Services
2.12.5 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 PharmAbcine, Inc.
2.13.1 PharmAbcine, Inc. Details
2.13.2 PharmAbcine, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 PharmAbcine, Inc. SWOT Analysis
2.13.4 PharmAbcine, Inc. Product and Services
2.13.5 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Merrimack Pharmaceuticals, Inc.
2.14.1 Merrimack Pharmaceuticals, Inc. Details
2.14.2 Merrimack Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Merrimack Pharmaceuticals, Inc. SWOT Analysis
2.14.4 Merrimack Pharmaceuticals, Inc. Product and Services
2.14.5 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novartis AG SWOT Analysis
2.15.4 Novartis AG Product and Services
2.15.5 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Insulin Like Growth Factor 1 Receptor Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Insulin Like Growth Factor 1 Receptor Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Insulin Like Growth Factor 1 Receptor Sales in China (2018-2019)
3.2.2 China Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Like Growth Factor 1 Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Insulin Like Growth Factor 1 Receptor Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Geography (2015-2020)
4.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Geography (2015-2020)
4.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Regions (2015-2020)
4.2 Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales and Forecast by Regions (2020-2025)
4.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Regions (2020-2025)
4.3 North America Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
4.4 Europe Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
4.6 South America Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Insulin Like Growth Factor 1 Receptor Market Size by Country (2015-2020)
5.1.1 North America Insulin Like Growth Factor 1 Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Country (2015-2020)
5.2 North America Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Country (2020-2025)
5.2.1 North America Insulin Like Growth Factor 1 Receptor Sales and Forecast by Country (2020-2025)
5.2.2 North America Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Country (2020-2025)
5.3 United States Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
5.4 Canada Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
5.5 Mexico Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country (2015-2020)
6.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020)
6.1.2 Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020)
6.2 Europe Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Insulin Like Growth Factor 1 Receptor Sales and Forecast by Country (2020-2025)
6.2.2 Europe Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Country (2020-2025)
6.3 Germany Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
6.4 United Kingdom Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
6.5 France Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
6.6 Russia Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
6.7 Italy Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2015-2020)
7.1.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region (2015-2020)
7.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Region (2020-2025)
7.3 China Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7.4 Japan Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7.5 Korea Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7.6 India Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7.7 Southeast Asia Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
7.8 Australia Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Insulin Like Growth Factor 1 Receptor Market Size by Country (2015-2020)
8.1.1 South America Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020)
8.1.2 South America Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020)
8.2 South America Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Country (2020-2025)
8.2.1 South America Insulin Like Growth Factor 1 Receptor Sales and Forecast by Country (2020-2025)
8.2.2 South America Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Country (2020-2025)
8.3 Brazil Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
8.4 Argentina Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2015-2020)
9.1.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2015-2020)
9.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
9.4 Turkey Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
9.5 Egypt Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
9.6 South Africa Insulin Like Growth Factor 1 Receptor Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Type (2015-2020)
10.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020)
10.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2015-2020)
10.1.3 Global Insulin Like Growth Factor 1 Receptor Price by Type (2015-2020)
10.2 Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Type (2020-2025)
10.2.1 Global Insulin Like Growth Factor 1 Receptor Sales and Forecast by Type (2020-2025)
10.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Type (2020-2025)
10.2.3 Global Insulin Like Growth Factor 1 Receptor Price and Forecast by Type (2020-2025)
10.3 China Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Type (2015-2025)
10.3.1 China Insulin Like Growth Factor 1 Receptor Market Size by Type (2015-2020)
10.3.2 China Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Application (2015-2020)
11.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020)
11.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2015-2020)
11.1.3 Global Insulin Like Growth Factor 1 Receptor Price by Application (2015-2020)
11.2 Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Application (2020-2025)
11.2.1 Global Insulin Like Growth Factor 1 Receptor Sales and Forecast by Application (2020-2025)
11.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Application (2020-2025)
11.2.3 Global Insulin Like Growth Factor 1 Receptor Price and Forecast by Application (2020-2025)
11.3 China Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Application (2015-2025)
11.3.1 China Insulin Like Growth Factor 1 Receptor Market Size by Application (2015-2020)
11.3.2 China Insulin Like Growth Factor 1 Receptor Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Insulin Like Growth Factor 1 Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insulin Like Growth Factor 1 Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 6. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 7. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 8. Astellas Pharma Inc. SWOT Analysis
Table 9. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 10. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Genmab A/S Basic Information, Manufacturing Base and Competitors
Table 12. Genmab A/S Insulin Like Growth Factor 1 Receptor Major Business
Table 13. Genmab A/S Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 14. Genmab A/S SWOT Analysis
Table 15. Genmab A/S Insulin Like Growth Factor 1 Receptor Product and Services
Table 16. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 18. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Major Business
Table 19. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 20. Boehringer Ingelheim GmbH SWOT Analysis
Table 21. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product and Services
Table 22. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Major Business
Table 25. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 26. AstraZeneca Plc SWOT Analysis
Table 27. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product and Services
Table 28. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 30. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Major Business
Table 31. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 32. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 33. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product and Services
Table 34. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Axelar AB Basic Information, Manufacturing Base and Competitors
Table 36. Axelar AB Insulin Like Growth Factor 1 Receptor Major Business
Table 37. Axelar AB Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 38. Axelar AB SWOT Analysis
Table 39. Axelar AB Insulin Like Growth Factor 1 Receptor Product and Services
Table 40. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Insmed Incorporated Basic Information, Manufacturing Base and Competitors
Table 42. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Major Business
Table 43. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 44. Insmed Incorporated SWOT Analysis
Table 45. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product and Services
Table 46. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 48. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Major Business
Table 49. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 50. Eli Lilly and Company SWOT Analysis
Table 51. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product and Services
Table 52. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 54. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Major Business
Table 55. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 56. Bristol-Myers Squibb Company SWOT Analysis
Table 57. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product and Services
Table 58. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Immunomedics, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 61. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 62. Immunomedics, Inc. SWOT Analysis
Table 63. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 64. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. ProteoThera, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 67. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 68. ProteoThera, Inc. SWOT Analysis
Table 69. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 70. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 72. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 73. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 74. Merck & Co., Inc. SWOT Analysis
Table 75. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 76. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. PharmAbcine, Inc. Basic Information, Manufacturing Base and Competitors
Table 78. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 79. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 80. PharmAbcine, Inc. SWOT Analysis
Table 81. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 82. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Merrimack Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 85. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 86. Merrimack Pharmaceuticals, Inc. SWOT Analysis
Table 87. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 88. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 90. Novartis AG Insulin Like Growth Factor 1 Receptor Major Business
Table 91. Novartis AG Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 92. Novartis AG SWOT Analysis
Table 93. Novartis AG Insulin Like Growth Factor 1 Receptor Product and Services
Table 94. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 96. Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 97. Key Players Insulin Like Growth Factor 1 Receptor Sales in China (2018-2019) (K Pcs)
Table 98. Key Players Insulin Like Growth Factor 1 Receptor Sales Market Share in China (2018-2019)
Table 99. Key Players Revenue of Insulin Like Growth Factor 1 Receptor in China (2018-2019) (USD Million)
Table 100. Global Insulin Like Growth Factor 1 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 101. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions (2015-2020)
Table 102. Global Insulin Like Growth Factor 1 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 103. Global Insulin Like Growth Factor 1 Receptor Sales and Forecast by Regions (2020-2025) (K Pcs)
Table 104. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions (2020-2025)
Table 105. Global Insulin Like Growth Factor 1 Receptor Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 106. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions (2020-2025) (USD Million)
Table 107. North America Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 108. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 109. North America Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 110. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 111. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) (K Pcs)
Table 112. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2025)
Table 113. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) (USD Million)
Table 114. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2025)
Table 115. Europe Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 116. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 117. Europe Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 118. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 119. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) (K Pcs)
Table 120. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2025)
Table 121. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) (USD Million)
Table 122. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2025)
Table 123. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 124. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 125. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 126. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 127. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) (K Pcs)
Table 128. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2025)
Table 129. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) (USD Million)
Table 130. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2025)
Table 131. South America Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 132. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 133. South America Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 134. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 135. South America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) (K Pcs)
Table 136. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2025)
Table 137. South America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) (USD Million)
Table 138. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2025)
Table 139. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 140. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 141. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 142. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 143. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) (K Pcs)
Table 144. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2025)
Table 145. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) (USD Million)
Table 146. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2025)
Table 147. China Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 148. China Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2015-2020)
Table 149. China Insulin Like Growth Factor 1 Receptor Revenue by Type (2015-2020) (USD Million)
Table 150. China Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2015-2020)
Table 151. China Insulin Like Growth Factor 1 Receptor Sales by Type (2020-2025) (K Pcs)
Table 152. China Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2020-2025)
Table 153. China Insulin Like Growth Factor 1 Receptor Revenue by Type (2020-2025) (USD Million)
Table 154. China Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2020-2025)
Table 155. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 156. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 157. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2015-2020) (USD Million)
Table 158. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2015-2020)
Table 159. Global Insulin Like Growth Factor 1 Receptor Price by Application (2015-2020) (USD/Pcs)
Table 160. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2020-2025) (K Pcs)
Table 161. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2020-2025)
Table 162. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2020-2025) (USD Million)
Table 163. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2020-2025)
Table 164. Global Insulin Like Growth Factor 1 Receptor Price by Application (2020-2025) (USD/Pcs)
Table 165. China Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 166. China Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
Table 167. China Insulin Like Growth Factor 1 Receptor Revenue by Application (2015-2020) (USD Million)
Table 168. China Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2015-2020)
Table 169. China Insulin Like Growth Factor 1 Receptor Sales by Application (2020-2025) (K Pcs)
Table 170. China Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2020-2025)
Table 171. China Insulin Like Growth Factor 1 Receptor Revenue by Application (2020-2025) (USD Million)
Table 172. China Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2020-2025)
Table 173. Direct Channel Pros & Cons
Table 174. Indirect Channel Pros & Cons
Table 175. Distributors/Traders/ Dealers List
Table 176. Customers of Insulin Like Growth Factor 1 Receptor
Table 177. Market Opportunities in Next Few Years
Table 178. Market Risks Analysis
Table 179. Market Drivers
List of Figures
Figure 1. Insulin Like Growth Factor 1 Receptor Picture
Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. BI-893923 Picture
Figure 4. CT-707 Picture
Figure 5. 1R-E1 Picture
Figure 6. ATL-1101 Picture
Figure 7. Others Picture
Figure 8. Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Insulin Like Growth Factor 1 Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Insulin Like Growth Factor 1 Receptor Sales Growth Rate (2015-2025) (K Pcs)
Figure 14. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturer in 2019
Figure 15. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Insulin Like Growth Factor 1 Receptor Revenue Market Share in China in 2019
Figure 17. Global Top 5 Insulin Like Growth Factor 1 Receptor Manufacturer Market Share in 2019
Figure 18. Top 3 Insulin Like Growth Factor 1 Receptor Players Market Share in China in 2019
Figure 19. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions in 2019
Figure 20. North America Insulin Like Growth Factor 1 Receptor Sales YoY Growth (2015-2025) (K Pcs)
Figure 21. North America Insulin Like Growth Factor 1 Receptor Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Insulin Like Growth Factor 1 Receptor Sales YoY Growth (2015-2020) (K Pcs)
Figure 23. Europe Insulin Like Growth Factor 1 Receptor Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales YoY Growth (2015-2020) (K Pcs)
Figure 25. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Insulin Like Growth Factor 1 Receptor Sales YoY Growth (2015-2020) (K Pcs)
Figure 27. South America Insulin Like Growth Factor 1 Receptor Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales YoY Growth (2015-2020) (K Pcs)
Figure 29. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 31. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 32. United States Insulin Like Growth Factor 1 Receptor Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Insulin Like Growth Factor 1 Receptor Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Insulin Like Growth Factor 1 Receptor Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 36. Germany Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Region 2018
Figure 42. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region 2018
Figure 43. China Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2019
Figure 50. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2019
Figure 51. Brazil Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Type in 2019
Figure 58. Global Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel